Free worldwide shipping (orders over 90 USD)
Pre-sale 2026 of Maxi UVB Presale HERE
.png){kind=logo}
Spring Allergies and Red Light: Can Photobiomodulation Reduce Inflammation and Pollen Season Symptoms?
A swollen nose, an itchy throat, and eyes that feel as if someone were throwing sand into them. For millions of people, this is a yearly spring ritual that is impossible to enjoy. Most reach for antihistamines, which suppress the symptoms but do not interfere with the inflammatory mechanism behind them. Photobiomodulation works directly on the cellular level, and clinical studies, including randomized controlled trials, confirm that it can relieve symptoms of allergic rhinitis and improve quality of life during pollen season. Find out how and why it works.
Article summary
- Why spring is a real burden on the immune system
- How photobiomodulation interferes with inflammatory processes
- What clinical studies say about red light and allergies
- A practical protocol during pollen season
- Summary
- Frequently asked questions
Why spring is a real burden on the immune system
Spring brings a combined stress scenario for the immune system: the massive presence of pollen allergens overlaps with a change in the light rhythm and disruption of the circadian rhythm, which weakens the natural regulation of inflammatory processes. Allergic rhinitis affects an estimated 20 to 30 percent of the adult population in Europe and is among the most common chronic inflammatory conditions. When pollen grains come into contact with the nasal mucosa, the immune system interprets them as a threat and triggers an inflammatory cascade.
- A key role is played here by immunoglobulin E (IgE), antibodies that activate the inflammatory alarm, and mast cells.
- After contact with the allergen, these cells release histamine and pro-inflammatory cytokines such as IL-4 and IL-5, which cause mucosal swelling, sneezing, itching, and tearing.
- The following wave of eosinophils (specialized inflammatory cells) then keeps the inflammation going for several more hours.
- And although many allergy-triggering factors cannot be directly controlled, inflammatory mediators can be influenced.
There is one more factor entering the inflammatory picture that is rarely considered. The morning cortisol response (the natural anti-inflammatory signal the body generates upon waking) directly depends on the quality of morning light signals. When cortisol does not rise sufficiently, the inflammatory response to pollen tends to be stronger. Light hygiene and the circadian setting of the body are therefore part of the allergy equation just as much as pollen itself. That is why it makes sense to be pragmatic: start red light therapy every spring before pollen season begins, not once the rhinitis has already fully flared up.
How photobiomodulation interferes with inflammatory processes
Photobiomodulation (red and near-infrared light therapy, known in English as Photobiomodulation or PBM) affects inflammation directly at the cellular level. Photons with wavelengths of 630 to 940 nm are absorbed by the enzyme cytochrome c oxidase (CCO), a key protein in the mitochondrial respiratory chain. This absorption triggers a cascade of biophysical changes: production of ATP (adenosine triphosphate) increases, the level of reactive oxygen species (ROS) is regulated, and anti-inflammatory signaling pathways are activated. [R]
For inflammation in allergies, the crucial effect involves NF-κB (nuclear factor kappa B, the main inflammatory regulator inside the cell). Red light therapy suppresses its activity, which leads to lower production of pro-inflammatory cytokines. In preclinical models of allergic rhinitis, reduced eosinophil infiltration and lower levels of IL-4, IL-17, and total IgE were demonstrated after light therapy was applied. These are exactly the inflammatory mediators responsible for swelling, itching, and irritation during pollen season. [R]
Wavelengths matter. The red spectrum around 630 to 670 nm acts on superficial tissues including the nasal mucosa and penetrates a few centimeters deep. Near-infrared wavelengths around 810 to 850 nm (NIR, Near Infrared Light) penetrate deeper and reach immune cells in lymphoid tissue. Devices that contain both spectral bands therefore work more comprehensively and target inflammation on several levels at once. Mitochondriak®devices are even the only ones to contain NIR up to 940 nm, together with 760 nm, which brings additional additive benefits.
What clinical studies say about red light and allergic rhinitis
Clinical evidence confirms that red light therapy reduces symptoms of allergic rhinitis in most patients. One clinical study followed 42 patients with chronic allergic rhinitis during 4 weeks of therapy using a wavelength of 650 nm. 68 percent of patients reported statistically significant improvement in nasal symptoms including congestion, discharge, and sneezing. The total quality-of-life score according to the standardized RQLQ questionnaire (Rhinoconjunctivitis Quality of Life Questionnaire) improved by 45 percent compared to baseline. [R]
Stronger evidence came from a randomized, double-blind, placebo-controlled clinical trial published in 2021 that included 67 patients with allergic rhinitis. The group receiving real red light therapy achieved statistically significantly better nasal symptom scores (p = 0.011) as well as improved quality of life (p = 0.036) compared to the placebo group. No serious adverse effects occurred during the entire treatment period. [R]
Another randomized controlled trial from 2022 compared intranasal light therapy with acupuncture in 80 patients. Both methods improved symptoms and quality of life after 4 weeks, and the effects persisted for another 4 weeks after the treatment ended. This suggests that the therapeutic effect of photobiomodulation is not only short-term and acute, but may also offer longer-lasting modulation of the inflammatory response. [R]
In plain language, this simply means that even red light therapy containing these critical wavelengths can help, and not only with allergies.
Practical protocol: how and when to use red light therapy during pollen season
For good results during pollen season, three things matter most: the right wavelengths, consistency, and proper timing. Red light therapy is not a drug. It is a tool that supports the natural regulation of the inflammatory response, and it works best when you make it part of your routine before pollen season reaches its peak, not when symptoms are already in full force.
- Wavelengths: Red spectrum 630-670 nm (superficial tissues, nasal mucosa) and NIR 810-850 nm (deeper penetration into lymphoid tissue and immune cells). Ideally, the device should contain both spectral bands.
- Therapy duration: 10 to 15 minutes daily. For local application to the face and sinuses, 10 minutes is enough. For full-body application, you can extend it to 15 to 20 minutes.
- Distance: 50 to 60 cm from the body.
- Target areas: The face and nasal sinus area (the inflammatory center), as well as the chest and neck area (support for the immune system and lymphatic tissue).
- Timing: In the morning (one to two hours after waking) or during the day. Not late in the evening, because red and NIR light activate cellular activity.
- Course duration: At least 3 to 4 weeks of regular therapy (once a day or every other day). The cited studies achieved measurable results specifically after 4 weeks.
Of course, if you want to combine red light therapy with conventional antihistamines or local corticosteroids, always consult your doctor first to make sure that a combined protocol is appropriate for you.
The new Mitochondriak® devices contain wavelengths of 630, 670, 760, 810, 830, 850 nm as the foundation of every model in the portfolio. Some models are extended with 940 nm for even deeper tissue penetration. All devices from our range are suitable for therapy during pollen season.
Summary
Photobiomodulation offers a science-backed, non-invasive way to support the regulation of the inflammatory response during pollen season. The spring allergy reaction is driven by a network of inflammatory mediators including IgE, histamine, and the cytokines IL-4 and IL-17. Red light therapy interferes with this network through activation of cytochrome c oxidase (CCO) in mitochondria, suppression of the inflammatory regulator NF-κB, and reduction of pro-inflammatory cytokine production.
Clinical studies, including randomized double-blind trials, confirm a reduction in allergic rhinitis symptoms after regular therapy with 630-850 nm over 4 weeks, with effects persisting even after treatment ends. Red light therapy is not a replacement for medication, but a complementary tool with a demonstrated mechanism of action.
Would you like to try red light therapy during pollen season as well? Take a look at Mitochondriak® red light panels with therapeutic wavelengths tailored for precise home use.
Frequently asked questions
Can red light therapy replace antihistamines for allergies?
Not directly. Red light therapy is not a replacement for antihistamines or any other prescribed treatment for allergic rhinitis. Antihistamines block histamine receptors and provide quick relief from acute symptoms. Photobiomodulation acts on inflammatory mechanisms at the cellular level and may modulate the intensity of the inflammatory response more long-term. These are complementary approaches acting on different links within the inflammatory cascade. Always consult your allergist before changing your treatment protocol.
Which part of the body should I shine light on in allergic rhinitis?
The most suitable area is the face and nasal sinuses, where the inflammation of the mucosa takes place directly. At the same time, shining light on the chest and neck area supports the lymphatic system and immune tissues in this zone. With a larger Mitochondriak® panel, you can combine local application to the face with full-body therapy in a single session. The optimal distance from the face is 30 to 60 cm for wavelengths of 630-850 nm. However, always remember that LESS is MORE, so start gradually, with goggles on or your eyes closed, and from a sufficient distance.
How long does it take for red light therapy to start working for allergies?
In the cited clinical studies, visible improvement in symptoms appeared after 3 to 4 weeks of regular therapy with a frequency of 3 to 5 sessions per week. Some studies also reported that the effect persisted for another 4 weeks after the treatment protocol ended. For good results during the spring season, we recommend starting therapy preventively in February or March, before the peak pollen load arrives.
Is red light therapy safe for pollen allergies?
Red and infrared light therapy (630-850 nm) is considered safe and non-invasive. In the available clinical studies, no serious adverse effects or contraindications specific to allergic rhinitis were reported. It is not invasive, it contains no chemicals, and when used correctly it does not damage the skin. The exception includes people diagnosed with photosensitivity or those taking photosensitizing medications. In that case, consult your doctor before starting therapy.
.jpg)
.jpg)
.jpg)